HYPERCVAD PROTOKOLÜ

Kaynaklar:

1- Kantarjian, H., D. Thomas, S. O'Brien, et al. 2004. "Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia." Cancer. 101(12):2788-2801. 

2- Kantarjian, H. M., S. O'Brien, T. L. Smith, et al. 2000. "Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia." J.Clin Oncol. 18(3):547-561. 

3- Thomas, D. A., S. O'Brien, S. Faderl, G. Garcia-Manero, A. Ferrajoli, W. Wierda, F. Ravandi, S. Verstovsek, J. L. Jorgensen, C. Bueso-Ramos, M. Andreeff, S. Pierce, R. Garris, M. J. Keating, J. Cortes and H. M. Kantarjian. 2010. "Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia." J Clin Oncol 28(24):3880-3889. 

4- Cortelazzo, S. M. Ponzoni, A. J. Ferreri, et al. 2011. "Lymphoblastic lymphoma." Crit Rev Oncol Hematol 79(3):330-343. 

5- Thomas, D. A, S. O'Brien, et al. (2004). "Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma." Blood 104(6): 1624-1630.